 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1155 | 回復(fù): 7 | ||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | ||
honghao81_2007金蟲 (小有名氣)
|
[求助]
大家誰有USP35，幫忙查一下替莫唑胺(Temozolomide)的質(zhì)量標(biāo)準(zhǔn)！先謝謝了。
|
|
| 可以發(fā)我郵箱honghao81_2000@163.com |
回復(fù)此樓» 猜你喜歡
中國藥科大學(xué)2026入學(xué)博士，藥物合成和設(shè)計(jì)經(jīng)驗(yàn)，放射化學(xué)及放射醫(yī)學(xué)研究
已經(jīng)有25人回復(fù)
-
2026年山東大學(xué)海洋學(xué)院生物與醫(yī)藥博士招生-李霞課題組
已經(jīng)有0人回復(fù)
-
藥理學(xué)論文潤色/翻譯怎么收費(fèi)?
已經(jīng)有243人回復(fù)
-
博士研究生招生
已經(jīng)有0人回復(fù)
-
使用MolAICal進(jìn)行多肽虛擬篩選教程-同樣適用于蛋白質(zhì)和核酸的虛擬篩選
已經(jīng)有1人回復(fù)
-
使用MolAICal計(jì)算藥物化學(xué)過濾器MCFs及MCE-18描述符
已經(jīng)有0人回復(fù)
-
使用MolAICal發(fā)現(xiàn)蛋白受體潛在的活性口袋及位點(diǎn)
已經(jīng)有0人回復(fù)
-
華理藥學(xué)學(xué)碩求調(diào)劑，總分324
已經(jīng)有0人回復(fù)
-
藥理學(xué)、臨床藥學(xué)方向 調(diào)劑
已經(jīng)有1人回復(fù)
-
澳門理工大學(xué)人工智能藥物發(fā)現(xiàn)中心招收2026級(jí)博士研究生（申請(qǐng)-考核制）
已經(jīng)有10人回復(fù)
honghao81_2007
金蟲 (小有名氣)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 528.5
- 紅花: 1
- 帖子: 156
- 在線: 28.2小時(shí)
- 蟲號(hào): 470422
- 注冊(cè): 2007-11-29
- 性別: GG
- 專業(yè): 合成藥物化學(xué)
4樓2012-07-09 14:55:28
yugijiang
木蟲 (著名寫手)
- 應(yīng)助: 661 (博士)
- 貴賓: 0.005
- 金幣: 4018.4
- 紅花: 11
- 帖子: 1790
- 在線: 178小時(shí)
- 蟲號(hào): 416091
- 注冊(cè): 2007-06-29
- 性別: GG
- 專業(yè): 藥物分析
【答案】應(yīng)助回帖
★ ★ ★ ★ ★ ★
感謝參與，應(yīng)助指數(shù) +1
honghao81_2007: 金幣+5, ★★★★★最佳答案 2012-07-09 15:18:02
癡夷子皮: 金幣+1, 謝謝交流。歡迎常來哦。 2012-07-10 11:34:09
感謝參與，應(yīng)助指數(shù) +1
honghao81_2007: 金幣+5, ★★★★★最佳答案 2012-07-09 15:18:02
癡夷子皮: 金幣+1, 謝謝交流。歡迎常來哦。 2012-07-10 11:34:09
|
Add the following: Temozolomide (tem'' oh zoe' loe mide). C6H6N6O2194.15 Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-; 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-as-tetrazine-8-carboxamide [85622-93-1]. DEFINITION Temozolomide contains NLT 98.0% and NMT 102.0% of C6H6N6O2, calculated on the as-is basis. [Caution—Temozolomide is cytotoxic. Great care should be taken to prevent inhaling particles of Temozolomide and exposure to the skin. ] IDENTIFICATION • A. Infrared Absorption 197K • B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. ASSAY [Note—Shake the solutions containing temozolomide to aid the dissolution. Do not sonicate. ] • Procedure Solution A: 0.5% (v/v) of glacial acetic acid in water Mobile phase: Solution A and methanol (96:4), containing 0.94 g/L of sodium 1-hexanesulfonate (0.005 M) Diluent: Dimethylsulfoxide. [Note—Use a freshly opened bottle. ] Standard solution: 1.0 mg/mL of USP Temozolomide RS in Diluent Sample solution: 1.0 mg/mL of Temozolomide in Diluent Chromatographic system (See Chromatography 621, System Suitability.) Mode: LC Detector: UV 270 nm Column: 4.6-mm × 15-cm; 5-µm packing L1 Flow rate: 1 mL/min Injection size: 10 µL System suitability Sample: Standard solution Suitability requirements Relative standard deviation: NMT 1.5% Tailing factor: NMT 1.9 Analysis Samples: Standard solution and Sample solution Calculate the percentage of C6H6N6O2 in the portion of Temozolomide taken: Result = (rU/rS) × (CS/CU) × 100 rU = = peak area from the Sample solution rS = = peak area from the Standard solution CS = = concentration of USP Temozolomide RS in the Standard solution (mg/mL) CU = = concentration of Temozolomide in the Sample solution (mg/mL) Acceptance criteria: 98.0%–102.0% calculated on the as-is basis IMPURITIES • Residue on Ignition 281: NMT 0.1% • Heavy Metals, Method II231: NMT 30 ppm • Organic Impurities [Note—Shake the solutions containing temozolomide to aid the dissolution. Do not sonicate. ] Mobile phase, Diluent, and Sample solution: Proceed as directed in the Assay. Standard solution: 2.0 µg/mL each of USP Temozolomide RS and USP Dacarbazine Related Compound A RS in Diluent System suitability solution: 0.5 µg/mL each of USP Temozolomide RS and USP Dacarbazine Related Compound A RS in Diluent, from the Standard solution Peak identification solution: Mix 5 mL of 0.1 N hydrochloric acid and 5 mL of 1.0 mg/mL of USP Temozolomide RS in Diluent. Heat the container for 1 h on a steam or boiling water bath. [Note—The preparation forms 2-azahypoxanthine, temozolomide acid, and dacarbazine related compound A. ] Chromatographic system: Proceed as directed in the Assay, using a run time of NLT 3.2 times the retention time of the temozolomide peak. System suitability Samples: Standard solution and System suitability solution Suitability requirements Resolution: NLT 2.0 between the temozolomide and dacarbazine related compound A peaks, Standard solution Relative standard deviation: NMT 10% for both dacarbazine related compound A and temozolomide peaks, System suitability solution Analysis Samples: Sample solution, Standard solution, and Peak identification solution Inject the Peak identification solution and identify the organic impurities according to the relative retention times given in Table 1. Calculate the percentage of dacarbazine related compound A (free base) in the portion of Temozolomide taken: Result = (rU/rS) × (CS/CU) × (Mr1/Mr2) × 100 rU = = peak area of dacarbazine related compound A from the Sample solution rS = = peak area of dacarbazine related compound A from the Standard solution CS = = concentration of USP Dacarbazine Related Compound A RS in the Standard solution (mg/mL) CU = = concentration of Temozolomide in the Sample solution (mg/mL) Mr1 = = molecular weight of dacarbazine related compound A (free base), 126.12 Mr2 = = molecular weight of dacarbazine related compound A (hydrochloride salt), 162.58 Calculate the percentage of any other individual impurity in the portion of Temozolomide taken: Result = (rU/rS) × (CS/CU) × (1/F) × 100 rU = = peak area of each impurity from the Sample solution rS = = peak area of temozolomide from the Standard solution CS = = concentration of USP Temozolomide RS in the Standard solution (mg/mL) CU = = concentration of Temozolomide in the Sample solution (mg/mL) F = = relative response factor for each individual impurity (see Table 1) Acceptance criteria: See Table 1. [Note—Disregard any unspecified impurity peaks less than 0.05%. ] Table 1 Name Relative Retention Time Relative Response Factor Acceptance Criteria, NMT (%) 2-Azahypoxanthinea 0.42 1.6 0.2 Temozolomide related compound Ab 0.53 1.0 0.5 Temozolomide acidc 0.84 1.0 0.1 Temozolomide 1.0 — — Dacarbazine related compound A (free base)d 1.37 — 0.1 Any unspecified impurity — 1.0 0.10 Total impurities — — 0.8 a 4a,5-Dihydro-4H-imidazo[4,5-d][1,2,3]triazin-4-one. b 4-Diazo-4H-imidazole-5-carboxamide. c 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid. d 5-Aminoimidazole-4-carboxamide. It is a free base of dacarbazine related compound A. SPECIFIC TESTS • Water Determination, Method Ic921: NMT 0.4% ADDITIONAL REQUIREMENTS • Packaging and Storage: Preserve in well-closed containers, and store at room temperature. • USP Reference Standards 11 USP Dacarbazine Related Compound A RS 5-Aminoimidazole-4-carboxamide hydrochloride. C4H6N4O·HCl 162.58 USP Temozolomide RS |
» 本帖已獲得的紅花（最新10朵）
honghao81_20072樓2012-07-09 14:03:22
honghao81_2007
金蟲 (小有名氣)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 528.5
- 紅花: 1
- 帖子: 156
- 在線: 28.2小時(shí)
- 蟲號(hào): 470422
- 注冊(cè): 2007-11-29
- 性別: GG
- 專業(yè): 合成藥物化學(xué)
3樓2012-07-09 14:44:51
yugijiang
木蟲 (著名寫手)
- 應(yīng)助: 661 (博士)
- 貴賓: 0.005
- 金幣: 4018.4
- 紅花: 11
- 帖子: 1790
- 在線: 178小時(shí)
- 蟲號(hào): 416091
- 注冊(cè): 2007-06-29
- 性別: GG
- 專業(yè): 藥物分析
5樓2012-07-09 15:24:34
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研]
 一志愿大連理工大學(xué)材料求調(diào)劑
+4
|
Gymno 2026-03-30 | 4/200 |
|
|---|---|---|---|---|
|
|
[考研] 生物學(xué)學(xué)碩，一志愿湖南大學(xué)，初試成績338 +7 | YYYYYNNNNN 2026-03-26 | 9/450 |
|
|
[考研] 332求調(diào)劑 +14 | 032500 2026-03-25 | 14/700 |
|
|
|
[考研] 295材料工程專碩求調(diào)劑 +10 | 1428151015 2026-03-27 | 10/500 |
|
|
|
[考研] 284求調(diào)劑 +14 | junqihahaha 2026-03-26 | 15/750 |
|
|
|
[考研] 0703化學(xué)/290求調(diào)劑/本科經(jīng)歷豐富/工科也可 +13 | 丹青奶蓋 2026-03-26 | 15/750 |
|
|
|
[考研] 294分080500材料科學(xué)與工程求調(diào)劑 +8 | 柳溪邊 2026-03-26 | 8/400 |
|
|
|
[考研] 一志愿北京理工大學(xué)本科211材料工程294求調(diào)劑 +8 | mikasa的圍巾 2026-03-28 | 8/400 |
|
|
|
[考研] 279求調(diào)劑 +4 | 蝶舞輕繞 2026-03-29 | 4/200 |
|
|
|
[考研] 330分求調(diào)劑 +5 | qzenlc 2026-03-29 | 5/250 |
|
|
|
[考研] 0703化學(xué)調(diào)劑，求導(dǎo)師收 +9 | 天天好運(yùn)來上岸?/a> 2026-03-24 | 10/500 |
|
|
|
[材料工程] 一志愿C9材料與化工專業(yè)總分300求調(diào)劑 +8 | 曼111 2026-03-24 | 9/450 |
|
|
|
[考研] 308求調(diào)劑 +7 | 墨墨漠 2026-03-27 | 7/350 |
|
|
|
[考研] 266分求材料化工冶金礦業(yè)等專業(yè)的調(diào)劑 +4 | 哇呼哼呼哼 2026-03-26 | 4/200 |
|
|
|
[考研] 081200-11408-276學(xué)碩求調(diào)劑 +4 | 崔wj 2026-03-26 | 4/200 |
|
|
|
[考研] 求調(diào)劑 一志愿 本科 北科大 化學(xué) 343 +6 | 13831862839 2026-03-24 | 7/350 |
|
|
|
[考研] 打過很多競賽，085406控制工程300分，求調(diào)劑 +3 | askeladz 2026-03-26 | 3/150 |
|
|
|
[考研] 一志愿哈工大，085400，320，求調(diào)劑 +4 | gdlf9999 2026-03-24 | 4/200 |
|
|
|
[考研] 347求調(diào)劑 +4 | L when 2026-03-25 | 4/200 |
|
|
|
[考研] 一志愿武理085500機(jī)械專業(yè)總分300求調(diào)劑 +3 | an10101 2026-03-24 | 7/350 |
|